#NASH

NASH, Alcohol Now the Top Reasons for Liver Transplants

A Mediterranean diet could help reduce the risk of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis.

Vitamin B-12 and folate not only lowered homocysteine levels in the blood but also improved liver inflammation in mice.

Researchers suggest that 67.3 million people are living with NAFLD in the United States and Canada.

If passed, the law would boost liver disease research and create a national strategy to tackle non-alcoholic steatohepatitis.

Optimal treatment for fatty liver disease may involve combining drugs with different mechanisms of action.

Twelve states have an adult obesity prevalence of 35% or more.

Many people with fatty liver disease have obesity, diabetes and other metabolic conditions.

As with HIV-negative individuals, non-alcoholic fatty liver disease is tied to diabetes and irregular blood lipids in those with HIV.

Obesity increased the risk of liver disease to a smaller extent, according to a meta-analysis study.

While women have a lower risk for NAFLD, once present, the disease advanced more rapidly.

This connection may be attributable to lower iron levels.

A new study analyzed how non-alcoholic fatty liver disease affects maternal health outcomes.

Non-alcoholic fatty liver disease can be driven by toxin exposure.

Instead of non-alcoholic fatty liver disease, they suggest calling it metabolic-associated fatty liver disease.

Researchers believe this finding may have implications for human health.

New research is emerging about how the respiratory virus spreads and how people can protect themselves and others.